Synthetic Cannabinoids Market Insights

Synthetic Cannabinoids Sales to Soar as Dronabinol Maintains its Lead Through 2029

2021-11-15 // 0 Comments

Synthetic Cannabinoids are anticipated to enter growth stage by mid-term forecast. Several biotech startups such as Emerald Health Pharmaceuticals, RespireRx etc are pioneering initiatives for [read full press release…]

Rapid Adoption of Therapeutic Drugs to Augment Demand of Synthetic Cannabinoids Through 2029

2021-08-30 // 0 Comments

Synthetic Cannabinoids are anticipated to enter growth stage by mid-term forecast. Several biotech startups such as Emerald Health Pharmaceuticals, RespireRx etc are pioneering initiatives for [read full press release…]

Synthetic Cannabinoids Market to create an absolute dollar opportunity of US$ 89 Mn during 2019 to 2029 | Noramco, Inc. CannBioRx Life Sciences, Hyasynth Biologicals, Inc

2021-02-25 // 0 Comments

Synthetic Cannabinoids are anticipated to enter growth stage by mid-term forecast. Several biotech startups such as Emerald Health Pharmaceuticals, RespireRx etc are pioneering initiatives for [read full press release…]

Home | Submit Press Release | Nationwide / EPR Network | Free Press Release Distribution | Real Time Press Release Distribution | Travel PR News | EuropaWire
© 2004-2026 Express-Press-Release.Net. Owned by EPR Network LLC. All Rights Reserved. All trade marks and names are owned by their respective owners.
RSS | Privacy | Disclaimer | TOS | Feedback
EPR Network LLC disclaims any content found in press releases published on its network - full disclaimer. Powered by WP. Theme by MH Themes
In the works: Consolidated Press Release Distribution | Social Press Release | Early Bird Press Release

The entire EPR Network is up for sale!

More info...

This is default text for notification bar

Learn more